Camp4 Therapeutics (CAMP) Current Leases (2023 - 2026)
Camp4 Therapeutics recorded quarterly Current Leases of $384000.0 in Q1 2026, up 34.27% quarter-over-quarter from $286000.0 in Q4 2025, and down 87.49% year-over-year from $3.1 million in Q1 2025.
Camp4 Therapeutics' Current Leases history runs 4 years deep, the most recent figure standing at $384000.0 for Q1 2026.
- In Q1 2026, Current Leases fell 87.49% year-over-year to $384000.0; the TTM figure through Mar 2026 stood at $384000.0 (down 87.49% YoY), while the FY2025 annual figure was $286000.0, down 90.45% from the prior year.
- Current Leases came in at $384000.0 for Q1 2026 at Camp4 Therapeutics, up from $286000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $3.2 million in Q3 2025 to a low of $26000.0 in Q2 2025.
- A 4-year average of $1.7 million and a median of $1.7 million in 2024 frame the typical range for Current Leases.
- Across the five-year window, Current Leases soared 745.76% in 2024 and sank 90.45% in 2025, its largest moves.
- Camp4 Therapeutics' Current Leases stood at $354000.0 in 2023, then jumped by 745.76% to $3.0 million in 2024, then plunged by 90.45% to $286000.0 in 2025, then soared by 34.27% to $384000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $384000.0, $286000.0, and $3.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | 384,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 384,000.00 |
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | 3.23 Mn |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 2.99 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Dec 31, 2023 | 354,000.00 |